Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 46.0243.5414.3510.2811.55

What is the latest EV/Core EBITDA ratio of VAISHALI PHARMA ?

The latest EV/Core EBITDA ratio of VAISHALI PHARMA is 46.02 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202546.02
Mar202443.54
Mar202314.35
Mar202210.28
Mar202111.55

How is EV/Core EBITDA of VAISHALI PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 46.02
5.70
Mar2024 43.54
203.41
Mar2023 14.35
39.59
Mar2022 10.28
-11.00
Mar2021 11.55 -

Other Financial Ratios of VAISHALI PHARMA


Compare EV/Core EBITDA ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹89.7 Cr -3.8% 4.9% -43.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,121.0 Cr 3.2% 12.5% 10.6% Stock Analytics
DIVIS LABORATORIES ₹181,396.0 Cr 2.9% 8.5% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,730.0 Cr 0.3% 5.7% 36.3% Stock Analytics
CIPLA ₹115,241.0 Cr 10.4% 15.9% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹111,126.0 Cr 4.8% 9% 10.8% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-3.8%

4.9%

-43.2%

SENSEX

-0.9%

-3.6%

-8.6%


You may also like the below Video Courses